Buckingham, BruceCheng, PeiyaoBeck, Roy W.Kollman, CraigRuedy, Katrina J.Weinzimer, Stuart A.Slover, RobertBremer, Andrew A.Fuqua, JohnTamborlane, WilliamDiabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups2017-04-122017-04-122015-06Buckingham, B., Cheng, P., Beck, R. W., Kollman, C., Ruedy, K. J., Weinzimer, S. A., … Tamborlane, W. (2015). CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes. Diabetologia, 58(6), 1167–1174. http://doi.org/10.1007/s00125-015-3559-y1432-0428https://hdl.handle.net/1805/12237AIMS/HYPOTHESIS: The aim of this work was to assess the association between continuous glucose monitoring (CGM) data, HbA1c, insulin-dose-adjusted HbA1c (IDAA1c) and C-peptide responses during the first 2 years following diagnosis of type 1 diabetes. METHODS: A secondary analysis was conducted of data collected from a randomised trial assessing the effect of intensive management initiated within 1 week of diagnosis of type 1 diabetes, in which mixed-meal tolerance tests were performed at baseline and at eight additional time points through 24 months. CGM data were collected at each visit. RESULTS: Among 67 study participants (mean age [± SD] 13.3 ± 5.7 years), HbA1c was inversely correlated with C-peptide at each time point (p < 0.001), as were changes in each measure between time points (p < 0.001). However, C-peptide at one visit did not predict the change in HbA1c at the next visit and vice versa. Higher C-peptide levels correlated with increased proportion of CGM glucose values between 3.9 and 7.8 mmol/l and lower CV (p = 0.001 and p = 0.02, respectively) but not with CGM glucose levels <3.9 mmol/l. Virtually all participants with IDAA1c < 9 retained substantial insulin secretion but when evaluated together with CGM, time in the range of 3.9-7.8 mmol/l and CV did not provide additional value in predicting C-peptide levels. CONCLUSIONS/INTERPRETATION: In the first 2 years after diagnosis of type 1 diabetes, higher C-peptide levels are associated with increased sensor glucose levels in the target range and with lower glucose variability but not hypoglycaemia. CGM metrics do not provide added value over the IDAA1c in predicting C-peptide levels.en-USPublisher PolicyBlood GlucoseanalysisC-PeptidebloodDiabetes Mellitus, Type 1Hemoglobin A, GlycosylatedmetabolismInsulinadministration & dosageArticle